Literature DB >> 26485309

Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT.

Cesar L Moreno1, Michelle E Ehrlich2, Charles V Mobbs3.   

Abstract

Huntington's disease (HD) is a fatal neurodegenerative disease characterized by metabolic, cognitive, and motor deficits. HD is caused by an expanded CAG repeat in the first exon of the HTT gene, resulting in an expanded polyglutamine section. Dietary restriction (DR) increases lifespan and ameliorates age-related pathologies, including in a model of HD, but the mechanisms mediating these protective effects are unknown. We report metabolic and behavioral effects of DR in the full-length YAC128 HD mouse model, and associated transcriptional changes in hypothalamus and striatum. DR corrected many effects of the transgene including increased body weight, decreased blood glucose, and impaired motor function. These changes were associated with reduced striatal human (but not mouse) HTT expression, as well as alteration in gene expression regulating histone acetylation modifications, particularly Hdac2. Other mRNAs related to Huntington's pathology in striatal tissue showed significant modulation by the transgene, dietary restriction or both. These results establish a protective role of DR in a transgenic model that contains the complete human HTT gene and for the first time suggest a role for DR in lowering HTT level, which correlates with severity of symptoms.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Creb-binding protein; Dietary restriction; HDAC; HTT; Huntington's disease; NF-κB; YAC128

Mesh:

Substances:

Year:  2015        PMID: 26485309      PMCID: PMC4820332          DOI: 10.1016/j.nbd.2015.09.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  71 in total

1.  Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Authors:  F C Nucifora ; M Sasaki; M F Peters; H Huang; J K Cooper; M Yamada; H Takahashi; S Tsuji; J Troncoso; V L Dawson; T M Dawson; C A Ross
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

2.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

3.  Effects of nutritional status and aging on leptin gene expression in mice: importance of glucose.

Authors:  T Mizuno; H Bergen; S Kleopoulos; W A Bauman; C V Mobbs
Journal:  Horm Metab Res       Date:  1996-12       Impact factor: 2.936

4.  Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington's disease.

Authors:  Hsin Hsien Yeh; Daniel Young; Juri G Gelovani; Andrew Robinson; Yvonne Davidson; Karl Herholz; David M A Mann
Journal:  Brain Res       Date:  2013-02-16       Impact factor: 3.252

5.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

6.  Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.

Authors:  A Jennifer Morton; Nigel I Wood; Michael H Hastings; Carrie Hurelbrink; Roger A Barker; Elizabeth S Maywood
Journal:  J Neurosci       Date:  2005-01-05       Impact factor: 6.167

7.  Interaction of Huntington disease protein with transcriptional activator Sp1.

Authors:  Shi-Hua Li; Anna L Cheng; Hui Zhou; Suzanne Lam; Manjula Rao; He Li; Xiao-Jiang Li
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

8.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

9.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

10.  SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease.

Authors:  Michal Mielcarek; Caroline L Benn; Sophie A Franklin; Donna L Smith; Ben Woodman; Paul A Marks; Gillian P Bates
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

View more
  9 in total

1.  Huntington's disease genotype suppresses global manganese-responsive processes in pre-manifest and manifest YAC128 mice.

Authors:  Anna C Pfalzer; Jordyn M Wilcox; Simona G Codreanu; Melissa Totten; Terry J V Bichell; Timothy Halbesma; Preethi Umashanker; Kevin L Yang; Nancy L Parmalee; Stacy D Sherrod; Keith M Erikson; Fiona E Harrison; John A McLean; Michael Aschner; Aaron B Bowman
Journal:  Metallomics       Date:  2020-07-22       Impact factor: 4.526

2.  Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport.

Authors:  Fatima Gasset-Rosa; Carlos Chillon-Marinas; Alexander Goginashvili; Ranjit Singh Atwal; Jonathan W Artates; Ricardos Tabet; Vanessa C Wheeler; Anne G Bang; Don W Cleveland; Clotilde Lagier-Tourenne
Journal:  Neuron       Date:  2017-04-05       Impact factor: 17.173

3.  Impaired Refinement of Kinematic Variability in Huntington Disease Mice on an Automated Home Cage Forelimb Motor Task.

Authors:  Cameron L Woodard; Marja D Sepers; Lynn A Raymond
Journal:  J Neurosci       Date:  2021-08-24       Impact factor: 6.167

Review 4.  Evaluating the beneficial effects of dietary restrictions: A framework for precision nutrigeroscience.

Authors:  Kenneth A Wilson; Manish Chamoli; Tyler A Hilsabeck; Manish Pandey; Sakshi Bansal; Geetanjali Chawla; Pankaj Kapahi
Journal:  Cell Metab       Date:  2021-09-22       Impact factor: 31.373

5.  Role of Hypothalamic Creb-Binding Protein in Obesity and Molecular Reprogramming of Metabolic Substrates.

Authors:  Cesar L Moreno; Linda Yang; Penny A Dacks; Fumiko Isoda; Jan M A van Deursen; Charles V Mobbs
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

6.  Protein aggregation activates erratic stress response in dietary restricted yeast cells.

Authors:  Ankan Kumar Bhadra; Eshita Das; Ipsita Roy
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

Review 7.  Uses for humanised mouse models in precision medicine for neurodegenerative disease.

Authors:  Remya R Nair; Silvia Corrochano; Samanta Gasco; Charlotte Tibbit; David Thompson; Cheryl Maduro; Zeinab Ali; Pietro Fratta; Abraham Acevedo Arozena; Thomas J Cunningham; Elizabeth M C Fisher
Journal:  Mamm Genome       Date:  2019-06-15       Impact factor: 2.957

Review 8.  Dietary regulation in health and disease.

Authors:  Qi Wu; Zhi-Jie Gao; Xin Yu; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-23

Review 9.  Glucose-Induced Transcriptional Hysteresis: Role in Obesity, Metabolic Memory, Diabetes, and Aging.

Authors:  Charles V Mobbs
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-28       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.